Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
    • Growth Factors & Cytokines
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy–induced ovarian damage in a mouse model

February 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Tissue Engineering

Multiplex Single-Cell Bioprinting for Engineering of Heterogeneous Tissue Constructs with Subcellular Spatial Resolution

February 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Clinical, Tissue Engineering

3D printing modality effect: Distinct printing outcomes dependent on selective laser sintering (SLS) and melt extrusion

February 2024 Bioprinting, Cell Therapy, Clinical, MedTech, Devices, & Materials, Tissue Engineering

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

February 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Tissue Engineering

Crosstalk between macrophages and mesenchymal stem cells shape patterns of osteogenesis and immunomodulation in mineralized collagen scaffolds

February 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Immunomodulation, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

Fructose vs. Glucose: Modulating Stem Cell Growth and Function Through Sugar Supplementation

January 2024 Bioprinting, Bioprocessing, Immunomodulation, Tissue Engineering

Solvent-cast 3D printing with molecular weight polymer blends to decouple effects of scaffold architecture and mechanical properties on mesenchymal stromal cell fate

January 2024 Bioprinting, Bioprocessing, Tissue Engineering

Calcium phosphate graphene and Ti3C2Tx MXene scaffolds with osteogenic and antibacterial properties

January 2024 Bioprinting, Orthopedic, Tissue Engineering

Low Molecular Weight Heparin Decreases Pro-coagulant Activity in Clinical MSC Products

December 2023 Bioprinting, Bioprocessing, Blood, Cardiovascular, Cell Therapy, Clinical, Immunomodulation, Orthopedic, Tissue Engineering

Subcutaneous White Adipose Tissue Independently Regulates Burn-induced Hypermetabolism Via Immune-adipose Crosstalk

December 2023 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Dermal and Wound, Immunomodulation, Tissue Engineering
Previous 1 2 3 4 … 11 12 13 14 15 16 17 18 19 20 21 … 29 30 31 32 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email